NCT04063111 is a NA clinical trial of vacuum assistant closure in Open Fracture of Tibia, sponsored by Assiut University.

Who is sponsoring NCT04063111?

NCT04063111 is sponsored by Assiut University.

What drugs are being tested in NCT04063111?

Interventions in NCT04063111: vacuum assistant closure, CONVENTIONAL DRESSING.

What condition does NCT04063111 study?

NCT04063111 studies Open Fracture of Tibia.

Is NCT04063111 still recruiting?

NCT04063111 is currently status unknown. Last updated 21 August 2019.

Last reviewed 2019-08-21 · How we verify

NCT04063111

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Vacuum in Open Fracture Tibia Grade III Type B

Status unknown NA Last updated 21 August 2019

What this trial tests

NA trial testing vacuum assistant closure in Open Fracture of Tibia in 60 participants. Status unknown.

Timeline

15 October 2019

Primary endpoint
15 October 2021

15 April 2022

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	15 October 2019
Primary completion	15 October 2021
Estimated completion	15 April 2022

Drugs / interventions tested

vacuum assistant closure
CONVENTIONAL DRESSING

Conditions studied

Open Fracture of Tibia — all drugs for Open Fracture of Tibia →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Open Fracture of Tibia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

\- Evaluate the role of VAC in decreasing the time needed for soft tissue coverage and definitive fixation in open IIIB tibial fractures

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04063111 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04063111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing